Point72 Europe’s Neurocrine Biosciences NBIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
Sell
-87
Closed -$11.5K 320
2023
Q4
$11.5K Buy
+87
New +$11.5K ﹤0.01% 389